Trade

with

Merus Labs International Inc
(NASDAQ: MSLI)
AdChoices
1.55
-0.02
-1.07%
After Hours :
-
-
-

Open

1.57

Previous Close

1.57

Volume (Avg)

4.41k (23.55k)

Day's Range

1.54-1.62

52Wk Range

1.01-2.59

Market Cap.

119.35M

Dividend Rate ( Yield )

-

Beta

1.15

Shares Outstanding

77.00M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 25.24M

    • Net Income

    • -2.76M

    • Market Cap.

    • 119.35M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -12.18

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.15

    • Forward P/E

    • -

    • Price/Sales

    • 2.53

    • Price/Book Value

    • 1.40

    • Price/Cash flow

    • 5.75

      • EBITDA

      • 13.82M

      • Return on Capital %

      • -3.15

      • Return on Equity %

      • -5.21

      • Return on Assets %

      • -3.15

      • Book Value/Share

      • 0.99

      • Shares Outstanding

      • 77.00M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 3.03

        • Credit Rating

        • -

        • Analysts

        • 4

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -4.40

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 12.84

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 82.66

            • 82.75

            • Pre-Tax Margin

            • -8.09

            • 39.38

            • Net Profit Margin

            • -12.18

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 96.00

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -139.90

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -146.90

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.25

              • 0.76

              • Current Ratio

              • 5.56

              • 2.92

              • Quick Ratio

              • 5.29

              • 2.35

              • Interest Coverage

              • 0.44

              • 38.02

              • Leverage Ratio

              • 1.38

              • 2.21

              • Book Value/Share

              • 1.11

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -23.81

                • 217.39

                • P/E Ratio 5-Year High

                • -41.39

                • 634.30

                • P/E Ratio 5-Year Low

                • -1.56

                • 124.82

                • Price/Sales Ratio

                • 2.44

                • 9.52

                • Price/Book Value

                • 1.35

                • 8.61

                • Price/Cash Flow Ratio

                • 5.75

                • 50.51

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -5.21

                        (-42.80)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -3.15

                        (-29.30)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -0.43

                        (-31.70)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • 1.91

                      • 1.48

                      • Asset Turnover

                      • 0.26

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      4.90M
                      Operating Margin
                      19.40
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      5.75
                      Ownership

                      Institutional Ownership

                      22.49%

                      Top 10 Institutions

                      22.32%

                      Mutual Fund Ownership

                      12.40%

                      Float

                      80.32%

                      5% / Insider Ownership

                      -

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Manulife Growth Opportunties

                      •  

                        2,100,300

                      • 8.50

                      • 2.99

                      • Beutel Goodman Small Cap Fund

                      •  

                        1,702,700

                      • 22.64

                      • 2.21

                      • Beutel Goodman Canadian Equity Fund

                      •  

                        993,500

                      • 22.64

                      • 1.29

                      • CIBC Canadian Small-Cap Fund

                      •  

                        917,290

                      • 0.00

                      • 1.19

                      • Renaissance Canadian Small-Cap Fund

                      •  

                        910,500

                      • 0.00

                      • 1.18

                      • IG Beutel Goodman Canadian Small Cap Fd

                      •  

                        360,800

                      • -0.11

                      • 0.47

                      • CIBC Canadian Equity Small Cap

                      •  

                        340,560

                      • 0.00

                      • 0.44

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • CIBC Global Asset Management Inc.

                      •  

                        3,756,891

                      • 0.00%

                      • 5.33

                      • Standard Life Assurance Co. of Canada

                      •  

                        2,696,200

                      • +22.64%

                      • 3.50

                      • Manulife Asset Management Limited

                      •  

                        2,401,493

                      • +16.79%

                      • 3.50

                      • Alberta Investment Management Corp

                      •  

                        1,496,731

                      • +18.06%

                      • 2.13

                      • Guardian Capital Inc

                      •  

                        786,400

                      • 0.00%

                      • 1.12

                      • Renaissance Technologies Corp

                      •  

                        587,900

                      • +52.58%

                      • 0.83

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Slow Growth

                      Style

                      Small Value

                      Merus Labs International Inc is incorporated on October 1, 2012 in British Columbia. The Company is a specialty pharmaceutical company. It acquires prescription medicines in various categories which include on patent but at maturity stage of product life cycle; branded generics; under promoted products; Niche market pharmaceuticals; and products with annual sales below critical threshold for large pharma. The Company competes with multinational pharmaceutical development corporations to small, single product companies that may limit their activities to a particular therapeutic area or region or territory. Competition also comes from generic companies, which develop and commercialize formulations that are identical to marketed brands.

                      Key People

                      Elie Farah

                      CEO/Director/President

                      Ahmad Doroudian, Ph.D.

                      CEO, Subsidiary/Director/President, Subsidiary/Vice Chairman of the Board

                      Andrew Patient

                      CFO

                      Dr. Ulrich Schoeberl, PhD

                      Managing Director, Geographical

                      Ali Moghaddam

                      Vice President, Divisional

                      • Merus Labs International Inc

                      • 100 Wellington Street

                      • Toronto, ON M5K 1H1

                      • CAN.Map

                      • Phone: +1 416 593-3725

                      • Fax: +1 416 593-4434

                      • meruslabs.com

                      Incorporated

                      2009

                      Employees

                      6

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: